[HTML][HTML] Associations between clinical data and computed tomography features in patients with epidermal growth factor receptor mutations in lung adenocarcinoma
Y Cao, H Xu, M Liao, Y Qu, L Xu, D Zhu… - International Journal of …, 2018 - Springer
Background To analyse the differences in computed tomography (CT) features between
patients with lung adenocarcinoma who have epidermal growth factor receptor (EGFR) …
patients with lung adenocarcinoma who have epidermal growth factor receptor (EGFR) …
FDG‐PET SUV‐max values do not correlate with epidermal growth factor receptor mutation status in lung adenocarcinoma
PM Putora, M Früh, J Müller - Respirology, 2013 - Wiley Online Library
Previous reports suggest a correlation between positron emission tomography with
fluorodeoxyglucose maximum standardized uptake value (SUV max) and epidermal growth …
fluorodeoxyglucose maximum standardized uptake value (SUV max) and epidermal growth …
[HTML][HTML] Radiomics signature as a predictive factor for EGFR mutations in advanced lung adenocarcinoma
D Hong, K Xu, L Zhang, X Wan, Y Guo - Frontiers in oncology, 2020 - frontiersin.org
Purpose: To develop and validate a radiomic signature to identify EGFR mutations in
patients with advanced lung adenocarcinoma. Methods: This study involved 201 patients …
patients with advanced lung adenocarcinoma. Methods: This study involved 201 patients …
CT features associated with epidermal growth factor receptor mutation status in patients with lung adenocarcinoma
Y Liu, J Kim, F Qu, S Liu, H Wang, Y Balagurunathan… - Radiology, 2016 - pubs.rsna.org
Purpose To retrospectively identify the relationship between epidermal growth factor
receptor (EGFR) mutation status, predominant histologic subtype, and computed …
receptor (EGFR) mutation status, predominant histologic subtype, and computed …
EGFR mutations are associated with higher incidence of distant metastases and smaller tumor size in patients with non-small-cell lung cancer based on PET/CT scan
J Guan, M Chen, N Xiao, L Li, Y Zhang, Q Li, M Yang… - Medical Oncology, 2016 - Springer
The study aimed to explore the correlation of epidermal growth factor receptor (EGFR)
mutation with tumor node metastasis (TNM) stage in patients with non-small-cell lung cancer …
mutation with tumor node metastasis (TNM) stage in patients with non-small-cell lung cancer …
Clinicoradiological features associated with epidermal growth factor receptor exon 19 and 21 mutation in lung adenocarcinoma
FN Zhao, YQ Zhao, LZ Han, YS Xie, Y Liu, ZX Ye - Clinical Radiology, 2019 - Elsevier
Aim To retrospectively identify clinicopathological and radiological characteristics that could
be independent predictors of epidermal growth factor receptor (EGFR) exon 19 and 21 …
be independent predictors of epidermal growth factor receptor (EGFR) exon 19 and 21 …
[HTML][HTML] Epidermal growth factor receptor (EGFR) mutations are exceptionally rare in thyroid transcription factor (TTF-1)-negative adenocarcinomas of the lung
N Somaiah, MJ Fidler, E Garrett-Mayer, A Wahlquist… - …, 2014 - ncbi.nlm.nih.gov
Results In the pilot cohort (N= 301) two of 224 specimens positive for EGFR mutations had
negative TTF-1 expression (sensitivity 99.1%, 95% confidence interval (CI) 96.8-99.9%) …
negative TTF-1 expression (sensitivity 99.1%, 95% confidence interval (CI) 96.8-99.9%) …
Role of [18F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer
C Caicedo, MJ Garcia-Velloso, MD Lozano… - European journal of …, 2014 - Springer
Purpose The tumour molecular profile predicts the activity of epidermal growth factor
receptor (EGFR) inhibitors in non-small-cell lung cancer (NSCLC). However, tissue …
receptor (EGFR) inhibitors in non-small-cell lung cancer (NSCLC). However, tissue …
[HTML][HTML] The Association of EGFR Mutations with Stage at Diagnosis in Lung Adenocarcinomas
Background The prognostic role of epidermal growth factor receptor (EGFR) mutations in
patients with lung adenocarcinomas remains controversial and the association between …
patients with lung adenocarcinomas remains controversial and the association between …
EGFR mutation analysis in sputum of lung cancer patients: a multitechnique study
AJ Hubers, DAM Heideman, Y Yatabe, MD Wood… - Lung cancer, 2013 - Elsevier
Objectives Epidermal growth factor receptor (EGFR) mutations have been identified in lung
adenocarcinomas and are associated with high response chance to EGFR tyrosine kinase …
adenocarcinomas and are associated with high response chance to EGFR tyrosine kinase …